SEC FORM 4
$1,431.00
RedHill Biopharma Ltd. (RDHL)
Sale of 14,310,000 shares at $0.0001 per share.
Reporting Person Raday Gilead · Officer Title Chief Operating Officer · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 6, 2026FILED +5 DAYS
Source: SEC Form 4 · 0001178913-26-004715 · filed 2026-10-06 · View filing →